ClinicalTrials.gg
Drug

Vinblastine clinical trials

Also written Velban and 29060-LE.

studies test it
87
open now
8
in phase 3
24
first study started
1992

Counted the way a researcher would: Vinblastine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Vinblastine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Vinblastine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Nov 1965 · VELBAN · NDA 012665 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vinblastine
52
vinblastine sulfate
19
VLB
7
Velsar
5
Velbe
4

Brand

Velban
17

Development codes

29060-LE
3

Other names

Vincaleukoblastine Sulfate
1
Alkaban-AQ
1

In one entry with another drug

Given together, or one or the other

ABVD
6

Studies by the year they started

87 studies that test it; most in 1997 (7)

Studies that test Vinblastine, by start year
YearStudies
19921
19941
19962
19977
19982
19991
20002
20014
20024
20033
20045
20051
20062
20076
20083
20092
20105
20114
20121
20133
20142
20153
20162
20174
20183
20193
20201
20213
20221
20231
20243
20252

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
11
Phase 2
54
Phase 3
24
Phase 4
3
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 83

M.D. Anderson Cancer Center (6) · St. Jude Children's Research Hospital (5) · Children's Oncology Group (5) · SWOG Cancer Research Network (4) · Alliance for Clinical Trials in Oncology (4) · University of Cologne (4) · National Cancer Institute (NCI) (3) · European Organisation for Research and Treatment of Cancer - EORTC (3)

Often tested with

Tested in the same studies.

Doxorubicin (44) · Dacarbazine (27) · Methotrexate (20) · Cyclophosphamide (16) · Cisplatin (16) · Bleomycin (15) · Prednisone (14) · Etoposide (13)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 4 in phase 3

Studies that test Vinblastine, phase 3 first.

Studies

Open first, then newest update. How each study uses Vinblastine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 87

See all 87 studies that test Vinblastine →

Given beside what is tested · 38 — Vinblastine is usual care or a partner of the new treatment

Showing 20 of 38.

As the comparator · 9 — what is tested is compared with Vinblastine

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Vinblastine · ClinicalTrials.gg INT008407

  • MeSH (NLM) D014747VinblastineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5V9KLZ54CYVINBLASTINEConfirmed FDA, NLM, Wikidata
  • RxNorm 11198Confirmed FDA, Wikidata
  • Wikidata Q282629vinblastineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C930VinblastineOne source FDA

Also registered as vinblastine sulfate (UNII N00W22YO2B · RxNorm 11199).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.